Piowin 15mg Tablet
Marketer
Serwin Pharmaceuticals
Salt Composition
Pioglitazone (15mg)
Overview Piowin 15mg Tablet
Glycemia-15 tablets are prescribed for adult patients managing type 2 diabetes. This medication assists in regulating blood glucose, thus mitigating the risk of severe diabetic complications such as visual impairment and renal dysfunction. Glycemia-15 may be administered independently or in conjunction with other medications, with or without food. Consistent daily dosing at the same time maximizes therapeutic effectiveness. Dosage adjustments are determined by your physician based on individual response. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose levels and increased risk of kidney damage, blindness, neuropathy, and limb loss. This medication forms part of a comprehensive diabetes management plan incorporating a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle modifications are key to effective diabetes control. Commonly reported side effects include headache, sinus inflammation, myalgia, and sore throat. Persistent or bothersome side effects warrant medical consultation. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or significant hepatic or renal impairment. Prior to commencing treatment, inform your physician of any history of cardiovascular disease, thyroid disorders, or endocrine imbalances. Pregnant or lactating individuals should seek medical advice before initiating therapy. Regular blood glucose monitoring is essential, and your doctor may recommend blood tests to track blood cell counts and liver function.
Uses of Piowin 15mg Tablet
Managing type 2 diabetes
Major Benefits of Piowin 15mg Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Piowin 15mg Tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Piowin 15mg Tablet:
- Headache
- Sore throat
- Sinus inflammation
- Muscle pain
How to use Piowin 15mg Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Piowin 15mg Tablets can be consumed with or without food, though consistent timing is recommended.
How Piowin 15mg Tablet works:
Glimepiride 15mg tablets are used to manage diabetes. Their action involves enhancing the body's responsiveness to insulin, thereby regulating blood glucose.
SAFETY ADVICE
AlcoholUNSAFE
Combining Piowin 15mg Tablet and alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Piowin 15mg tablets during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCAUTION
The use of Piowin 15mg Tablets during breastfeeding requires careful consideration. Breastfeeding is advised against until the maternal course of treatment concludes and the medication is fully cleared from the mother's system. Close monitoring of the infant's blood glucose levels is necessary while the mother is taking Piowin 15mg Tablets.
DrivingSAFE
Driving ability is typically unaffected by Piowin 15mg Tablets.
KidneySAFE IF PRESCRIBED
For patients with kidney impairment, Piowin 15mg tablets are considered safe. No alteration of the Piowin 15mg tablet dosage is necessary.
LiverCAUTION
Individuals with liver impairment should use Piowin 15mg Tablets cautiously, potentially requiring a modified dosage. Medical advice is essential. Piowin 15mg Tablets are contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Piowin 15mg Tablet :
Omit any missed Piowin 15mg Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Piowin 15mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Thiazolidinedione-based compound |
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
| Action Category | PPARγ agonist (thiazolidinedione) |
3,018 People bought this recently